These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 852540)

  • 1. Diabetic microangiopathy in KK mice. II. Suppression of Glomerulosclerosis by pyridinolcarbamate.
    Reddi AS; Oppermann W; Velasco CA; Camerini-Davalos RA
    Exp Mol Pathol; 1977 Apr; 26(2):325-39. PubMed ID: 852540
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic microangiopathy in KK mice. IV. Effect of pyridinolcarbamate on kidney glucosyltransferase activity and glomerulosclerosis.
    Reddi AS; Oppermann W; Chen M; Camerini-Davalos RA
    Exp Mol Pathol; 1978 Oct; 29(2):149-55. PubMed ID: 689139
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic glomerulosclerosis in KK mice and its prevention by glyburide and pyridinolcarbamate.
    Camerini-Davalos RA; Reddi AS; Ehrenreich TH; Strugatz LH; Oppermann W
    Adv Exp Med Biol; 1979; 119():387-400. PubMed ID: 115232
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic microangiopathy in KK mice. V. Effect of early glyburide treatment of kidney glucosyltransferase activity.
    Reddi AS; Oppermann W; Velasco C; Camerini-Davalos RA
    Exp Mol Pathol; 1978 Dec; 29(3):442-7. PubMed ID: 102528
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of angioprotectors on the glomerular filtration rate and vascular permeability in diabetic angiopathies].
    Tirkina TN; Mirkhodzhaev AKh; Alekseev IuP; Ionushas BS; Kasymova SD
    Probl Endokrinol (Mosk); 1979; 25(4):11-6. PubMed ID: 471968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis.
    Reddi AS; Velasco CA; Reddy PR; Khan MY; Camerini-Davalos RA
    Exp Mol Pathol; 1990 Oct; 53(2):140-51. PubMed ID: 2148155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study of the anti-inflammatory action of pyridinolcarbamate].
    Shvarts GIa; Liberman SS; Mashkovskiĭ MD; Berliand EA
    Farmakol Toksikol; 1975; 38(4):434-6. PubMed ID: 1213130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
    Parodi FA; Caputo G
    Clin Ter; 1976 Dec; 79(6):571-81. PubMed ID: 1009761
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of parmidin on the course of tuberculosis under isoniazid therapy].
    Solov'eva IP; Makinskiĭ AI
    Vrach Delo; 1984 Sep; (9):70-3. PubMed ID: 6390963
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
    Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
    [No Abstract]   [Full Text] [Related]  

  • 11. Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glycoxidation, kidney weight and albuminuria in the diabetic kk mouse.
    Lubec B; Aufricht C; Amann G; Kitzmüller E; Höger H
    Nephron; 1997; 75(2):213-8. PubMed ID: 9041544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P; Abbadessa V; Pecorella M; Cajozzo A
    Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
    Makinskiĭ AI; Safarov RN; Fondaminskaia LD; Semenova AS; Fedotova NN
    Probl Tuberk; 1979 Jan; (1):26-30. PubMed ID: 368764
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the effectiveness of anginine treatment of diabetic microangiopathies].
    Spesivtseva VG; Frenkel' VKh; Mamaeva GG; Sokolovskiĭ GA; Kukes VG
    Sov Med; 1975 Jul; (7):42-5. PubMed ID: 1216049
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of the electrophoretic tracing of the serum glycoproteins in diabetic subjects treated with pyridinolcarbamate].
    Notarbartolo A; Rini GB; Di Fede G
    Boll Soc Ital Cardiol; 1973; 18(4):379-83. PubMed ID: 4807078
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution of angioxine to the vascular protection of the diabetic].
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():319-27. PubMed ID: 796526
    [No Abstract]   [Full Text] [Related]  

  • 17. Kidney disease in KK mice: effect of glyburide.
    Camerini-Davalos RA; Reddi AS
    Adv Exp Med Biol; 1988; 246():297-303. PubMed ID: 2977928
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyridinolcarbamate in the long-term treatment of ischaemic heart disease.
    Gulyás A; Szám I
    Ther Hung; 1976; 24(2):63-6. PubMed ID: 982341
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
    Fényes G; Gótzy G; Fehrentheil L
    Ther Hung; 1975; 23(2):64-66. PubMed ID: 1188705
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial suppression by pyridinolcarbamate of growth and necrosis of atherosclerotic lesions in swine subjected to an atherogenic regimen that produces advanced lesions.
    Lee WM; Lee KT; Thomas WA
    Exp Mol Pathol; 1979 Feb; 30(1):85-93. PubMed ID: 421864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.